Pneumatic Nebulizers Market Size, Share & Trends Report

Pneumatic Nebulizers Market Size, Share & Trends Analysis Report By Type (Vented, Breath-Actuated), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 - 2025

  • Published Date: Nov, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-194-8
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 75

Industry Insights

The global pneumatic nebulizers market size was valued at USD 490.6 million in 2015 and is projected to grow at a CAGR of 6.2% over the forecast period. The high growth is attributed to the rising demand for non-invasive methods of drug delivery, increasing incidence of various respiratory disorders, and the surging geriatric population.

The increasing incidence of respiratory diseases is a vital impact rendering factor supporting the growth of this sector. In 2011, according to the American Lung Association, around 10 million Americans suffered from chronic bronchitis. Moreover, the chances of developing chronic bronchitis increase with age as it was determined that out of those 10 million cases around 70.0% of people were above 65 years of age.

U.S. pneumatic nebulizers market, by type, 2014 - 2025 (USD Million)

U.S. pneumatic nebulizers market

Nebulizers are electrically powered or battery-operated devices used to administer liquid drug in the form of mist and aerosol. The increased surface area yields a better drug therapeutic effect as compared to inhalation therapy. The device is used to treat various respiratory disorders such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and cystic fibrosis. Moreover, the increasing application of pneumatic nebulizer as a method for treatment of diabetes, migraine, and cancer is expected to drive the demand for pneumatic nebulizers.

Government initiatives and organization funding deployed to improve the current treatment alternatives for respiratory conditions are also expected to result in an upsurge in the demand for inhalation devices. The American Heart Association along with the National Association for Stock Car Auto Racing (NASCAR) launched a DRIVE4COPD campaign in 2011. Through this partnership, NASCAR was responsible for screening around three million NASCAR fans for COPD.

Another initiative expected to positively influence the market is the COPD population screener by the COPD Foundation. Using this screener, American citizens who are 35 years and older are screened for COPD through a five-question test. If the screener indicates positive results, the individual is advised to visit a healthcare professional or call the COPD helpline, thereby raising awareness among the population to enable early intervention.

Product Insights

Vented product type held the majority share of the pneumatic nebulizers market in 2015 owing to their better availability and affordability as compared to breath-actuated nebulizers. Moreover, in February 2014, Kitabis Pak was approved by the FDA. This is the first of its kind reusable nebulizer delivering PARI LC PLUS and tobramycin in combination to patients with cystic fibrosis.

Pneumatic nebulizers market, by product, 2015

Pneumatic nebulizers market

However, the sector players are now introducing breath-actuated nebulizers with higher drug delivery capacity and lesser dosage wastage features. Thus, this product type, delivering advanced inhalation therapy is expected to be the fasted growing segment during the forecast period. AeroEclipse II BAN by Monaghan Medical Corporation is an approved breath-actuated nebulizer, with advancement implementing minimal drug wastage, thus encouraging other players in the vertical to launch similar products.

Regional Insights

In 2015, North America accounted for the maximum revenue share. High incidence of COPD and various government initiatives are some of the contributing factors. In 2014, according to the CDC, COPD was established as the third-most important cause of death with 15.7 million people diagnosed with COPD. Moreover, the Ontario government has established two insurance programs called Home Oxygen Program and the Assistive Devices Program to promote higher diagnosis and treatment of COPD. The program covers up to 75% of the equipment cost.

While North America dominates the market, Asia Pacific is expected to be the fastest-growing region. Developing economies, such as China and India, are attracting international players to expand their geographic reach. In May 2015, Apex Medical Corporation launched their operations in India spanning across the following product verticals: support surface, respiratory, and autoclaves. The company aims to invest around USD 15 million in the initial development phase.

Pneumatic Nebulizers Market Share Insights

Some of the key players operating in this space include Omron Corporation; Philips; PARI Pharma; GE Healthcare; Allied Healthcare; CareFusion Corporation; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.

Contributors in this sector are developing better technologies to enhanced rug inhalation therapy. In February 2015, PARI Medical received FDA approval for its eRapid powered system. This device delivers Genentech’s Pulmozyme for cystic fibrosis and is designed to expedite the dosage preparation time such that it cuts down the overall treatment time from eight to two minutes.

Moreover, acquisitions undertaken to either expand the product portfolio or to enable market entry into potentially profitable regions are being increasingly witnessed in this sector. In September 2014, Omron Healthcare acquired NS Indústria de Aparelhos Médicos for USD 84 million to expand its nebulizer portfolio and accelerate product sales in Brazil.

Report Scope



Base year for market estimation


Actual estimates/Historic market data


Forecast period

2016 - 2025

Market representation

Market revenue in USD Million & CAGR from 2016 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America & MEA

Country scope

U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa

Report coverage             

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global pneumatic nebulizers market on the basis of type and region:

  • Type Outlook (Revenue, USD Million, 2014 - 2025)

    • Breath-actuated

    • Vented

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

        • Canada

      • Europe

        • UK

        • Germany

      • Asia Pacific

        • Japan

        • China

        • India

      • Latin America

        • Brazil

        • Mexico

      • MEA

        • South Africa

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPA norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities